Chicago Tribune - July 5, 2007
Bruce Japsen, Tribune staff reporter, bjapsen@tribune.com
Brazil is among an increasing number of countries playing hardball with the drug industry over prices it pays to treat its citizens with the HIV virus.
This spring, for example, Brazil moved to break a patent held by Merck & Co. on one of the New Jersey company's AIDS drugs by agreeing to import a cheaper generic version from a company in India.
In Abbott's case, there is no generic version of Kaletra tablets. Abbott confirmed it will charge Brazil 73 cents a pill this year and 63 cents next year. Brazil has been paying $1.04 per pill. The move will save Brazil $10 million a year, Abbott said.
Brazil now pays what Abbott in March said it would charge 45 developing nations.
070705
CT070702
Copyright © 2007 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611 http://www.chicagotribune.com
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .